Vor Biopharma Inc stock is traded at $18.66, with a volume of 636,355. It is down -7.26% in the last 24 hours and up +1.91% over the past month. Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Previous Close:
$20.12
Open:
$20.08
24h Volume:
636,355
Relative Volume:
0.87
Market Cap:
$1.15B
Revenue:
-
Net Income/Loss:
-$883.08M
P/E Ratio:
-
EPS:
-$333.48
Net Cash Flow:
-$150.65M
1W Performance:
-5.18%
1M Performance:
+1.91%
6M Performance:
+17.36%
1Y Performance:
-1.63%
1-Day Range:
$0.00$0.00
1-Week Range:
$18.33$20.70
52-Week Range:
$6.50$26.00
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma IncSector
HealthcareIndustry
BiotechnologyPhone
617-655-6580Address
500 BOYLSTON STREET, BOSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS